FUJIFILM Diosynth Biotechnologies is strategically expanding

HOLLY SPRINGS AND RALEIGH, NORTH CAROLINA, Nov. 15, 2022 (GLOBE NEWSWIRE) — FUJIFILM Diosynth Biotechnologies is expanding its strategic partnership with North Carolina State University (NC State) to address future innovation opportunities through new research projects, sustainable facility design and advances in Bioprocessing at future cell culture biomanufacturing site in Holly Springs. The strategic partnership will focus on areas of research and facility design to support FUJIFILM Diosynth Biotechnologies’ goal of achieving net-zero carbon emissions by 2030 for its new $2 billion Holly Springs site. In addition, the strategic partnership will create opportunities for the organizations to develop new bioprocess development techniques using machine learning, artificial intelligence and analytical methods.

This agreement builds on the existing partnership which has resulted in projects to advance sustainability at the Holly Springs site and to empower FUJIFILM Diosynth Biotechnologies talent at both North Carolina sites.

With the Holly Springs site scheduled to open by 2025, NC State landscape architecture and environmental planning professionals are collaborating with FUJIFILM Diosynth Biotechnologies on sustainable site development plans to achieve carbon neutrality. The future site design aims for 100% use of clean energy, implementation of state-of-the-art waste management and recycling, among other sustainability plans.

NC State College of Design researchers are conducting an ecosystem services assessment to set and monitor environmental performance goals. The plan will guide the sustainable development of the site and ensure it delivers optimal benefits to the surrounding community, for example by improving wastewater treatment and identifying the most environmentally friendly ways to incorporate pollinators, natural learning gardens and other biodiversity features.

The agreement was signed at a ceremony on November 11, 2022 at NC State’s Raleigh campus. Randy Woodson, Chancellor of the NC, and Kenneth Bilenberg, Vice President and General Manager of the Holly Springs site for FUJIFILM Diosynth Biotechnologies, and other guests were present. The first project under the new agreement is scheduled to start in late 2022

“We have built a strong relationship with NC State that began well before our announcement in 2021 to build North America’s largest end-to-end cell culture manufacturing facility in Holly Springs, and has already resulted in numerous improvements to a plant design with sustainability at its core,” said Bilenberg. “The research agreement will allow for increased collaboration with the university, and NC State has the expertise to meet our ambitious goals for the new site not only in terms of sustainability and environmental protection, but also in evaluating future greenway development and conservation opportunities.” manufacturing efficiency projects. ”

“We are proud to partner with FUJIFILM Diosynth Biotechnologies to develop sustainability solutions,” said Chancellor Woodson. “The research agreement will strengthen collaboration, provide new opportunities for faculty and students, and help FUJIFILM Diosynth Biotechnologies achieve its goals.”

The existing partnership has already resulted in improvements to the sustainable design of the new Holly Springs location. For example, NC State conducted a pre-development biodiversity and beneficial use assessment at the prospective Holly Springs site and identified design strategies to minimize environmental impact, preserve biodiversity and restore habitat, including restoring more than 30 acres at the site site. site.

NC State and FUJIFILM Diosynth Biotechnologies also have an existing training partnership that balances business needs with university talent and research. More than 200 employees have already completed further training at the NC State Biotechnology Training and Education Center (BTEC).

About FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, is a leading global contract development and manufacturing partner for the development and manufacture of biologics, vaccines and advanced therapies. The company operates a global network with main locations in the United States, Great Britain and Denmark and is building a new manufacturing facility in Holly Springs, North Carolina, USA. FUJIFILM Diosynth Biotechnologies has over thirty years of experience in the development and manufacture of recombinant proteins, vaccines, monoclonal antibodies and other large molecules, viral products and medicinal countermeasures expressed in a variety of microbial, mammalian and host/viral systems . The company offers a comprehensive list of services from cell line development using its proprietary pAVEway™ and Apollo™X microbial cell line systems to process development, analytical development, clinical and FDA-approved commercial manufacturing. Mitsubishi Corporation is a 20 percent shareholder of FUJIFILM Diosynth Biotechnologies UK sites, Research Triangle Park, North Carolina, Watertown, Massachusetts and College Station, Texas. For more information, visit: www.fujifilmdiosynth.com.

About FUJIFILM Holdings Corporation
FUJIFILM Holdings Corporation, Tokyo, uses its extensive knowledge and proprietary core technologies to create value through innovation with its products and services in the healthcare, materials, business innovation and imaging business areas. Our relentless pursuit of innovation focuses on creating social value and improving the lives of people worldwide. Fujifilm is committed to environmental stewardship and good corporate citizenship. More information on Fujifilm’s Sustainable Value Plan 2030 can be found here. For the fiscal year ended March 31, 2022, the company had global sales of approximately 2.5 trillion yen (US$21 billion at an exchange rate of 122 yen/dollar). Visit www.fujifilmholdings.com for more information.

About NC State
NC State is a preeminent educational and research organization that excels in all disciplines and contributes more than $6.5 billion annually to the North Carolina economy. More than 37,000 undergraduate and graduate students learn by doing — conducting original research, starting new businesses, forging connections with top employers, and serving local and global communities. NC State’s 9,000 faculty and staff are global leaders in their fields, bridging the gap between academic disciplines and training high-calibre students to meet tomorrow’s challenges. Together they build strong partnerships with industry, government, nonprofit organizations and academia to change our world for the better. Visit www.ncsu.edu for more information.

  • FUJIFILM Diosynth Biotechnologies Expands Strategic Partnership with NC State